Ultrasound vs. MRI: a cheaper way to diagnose hip pinching?

NCT ID NCT07198646

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 30 people with hip pain caused by a condition called ischiofemoral impingement, where the hip bones pinch soft tissues. Researchers wanted to see if ultrasound measurements of the hip space and muscle thickness match up with MRI scans, which are the current standard. If ultrasound proves reliable, it could offer a faster and cheaper way to diagnose this condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

30 people

The number who actually took part.

Started

Oct 2024

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1. Patients older than 18 years and younger than 65 years. 2. Patients diagnosed by MRI 3. Those with a body mass index below 25 kg/m2 4. those with hip pain or positive physical examination tests

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients older than 18 years and younger than 65 years. 2. Patients diagnosed by MRI 3. Those with a body mass index below 25 kg/m2 4. those with hip pain or positive physical examination tests Exclusion Criteria: 1. Sciatic nerve damage detected on EMG 2. Patients with operative ischiofemoral decompression 3. Corticosteroid or any injection to the hip in the last 3 months 4. History of peripheral nerve damage 5. Femoroacetabular impingement 6. Pregnancy 7. Malignancy 8. Inflammatory pathologies: rheumatic, septic 9. Coxarthrosis-Kelgren-Lawrence grade 3-4 10. Those who have undergone hip arthroplasty/surgery 11. Causes of lumbar radiculopathy, spondylolisthesis 12. Patients with increased femoral anteversion - patients with increased hip internal rotation (Toe-in)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip pain chronic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seyrantepe Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey

    Istanbul, sarıyer, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.